Ro
Ro (Roman Health Ventures) is a direct-to-consumer telehealth company offering treatments for men's and women's health, weight loss (including GLP-1s), fertility and dermatology through subsidiaries Roman, Rory, Zero and Modern Fertility. Founded in 2017 and headquartered in New York, Ro has raised approximately $1B at a $7B valuation, most recently in a 2022 Series D.
Company snapshot
- Active
- Total funding
- $1.0B
- Funding rounds
- 7
- Last round (Series D)
- $150M
- Last round date
- Mar 2022
- Founded
- 2017
- Employees
- 501-1000
- Headquarters
- New York, New York, United States
Last round vs total raised$150M of $1.0B
Founders
Zachariah Reitano, Saman Rahmanian, Rob Schutz
Industries
- Telehealth
- Healthcare
- Direct-to-Consumer
- Digital Health
Notable investors
| Investor | Role |
|---|---|
| General Catalyst | Lead |
| FirstMark Capital | Lead |
| TQ Ventures | Co-investor |
| ShawSpring Partners | Lead |
| Initialized Capital | Co-investor |
| BoxGroup | Co-investor |